Albumin controversy continues

doi:10.1136/bmj.318.7181.464

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Meta-analysis has affected use of albumin

Richard Patey, Specialist registrar in paediatrics,
Georgina Wilson, Senior house officer in paediatrics,
Tony Hulse, Consultant paediatrician

Paediatric Department, Maidstone Hospital, Maidstone, Kent ME16 9QQ
Dalhousie University, Halifax, Nova Scotia, Canada B3H 2Y9

EDITOR—With the recent Cochrane Injuries Group meta-analysis regarding albumin1 and subsequent correspondence in mind, we undertook a postal survey of paediatric departments in the South East Thames region. We asked clinicians which fluid (crystalloid, albumin, or other colloid) would be used in a variety of scenarios, before and after 25July 1998,in light of the meta-analysis. Altogether 12of 13departments replied, which equals a 92% response rate (table).

View this table: